TEAEs most frequently reported by subjects administered 60 mg HEC30654 included lymphocytopenia (100%), leukopenia (87.5%), elevated C-reactive protein (75.0%), neutropenia (62.5%), fever (100%), headache (75.0%), and myalgia (75.0%). This evidence concerns the gene CRP and neutropenia.